Indian and Chinese companies mainly sought to exploit their
cost advantage by attacking low-margin segments such as textiles
(Birla) and generic pharmaceuticals (Ranbaxy), sometimes with
unbranded products but often as subcontractors for original
equipment manufacturers (OEMs).
The profits were then invested in product development, allowing
them to move up into higher profitability segments in developed
nations.
More...
If you are not registered with the site, please register now to read the rest of this page.
If you are registered, please sign in to read the rest of this page.
